|
2026-05-15 |
2026-05-13 |
S
Sale
|
Non-Executive Director
Large shareholder
|
7,854
+3.6%
401.94
US$3,151,149
|
7,854
+3.6%
|
401.94
|
US$3,151,149
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Non-Executive Director
Large shareholder
|
69,263
-29.6%
257.89
US$408,726
|
69,263
-29.6%
|
257.89
|
US$408,726
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Non-Executive Director
Large shareholder
|
2,622
+24.6%
150.26
US$3,505,107
|
2,622
+24.6%
|
150.26
|
US$3,505,107
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Non-Executive Director
Large shareholder
|
12,735,301
-100.0%
15.17
US$193,169,046
|
12,735,301
-100.0%
|
15.17
|
US$193,169,046
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Non-Executive Director
Large shareholder
|
19,102,952
-100.0%
15.17
US$289,753,576
|
19,102,952
-100.0%
|
15.17
|
US$289,753,576
|
|
|
2026-03-10 |
2026-03-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
10,000,000
-44.0%
15.27
US$152,700,000
|
10,000,000
-44.0%
|
15.27
|
US$152,700,000
|
|
|
2026-03-10 |
2026-03-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
15,000,000
-44.0%
15.27
US$229,050,000
|
15,000,000
-44.0%
|
15.27
|
US$229,050,000
|
|
|
2026-03-10 |
2026-03-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
15,000,000
-44.0%
15.27
US$229,050,000
|
15,000,000
-44.0%
|
15.27
|
US$229,050,000
|
|
|
2025-12-10 |
2025-12-08 |
S
Sale
|
Chairman & CEO
Executive Director
|
39,243
-100.0%
16.45
US$645,547
|
39,243
-100.0%
|
16.45
|
US$645,547
|
|
|
2025-12-10 |
2025-12-08 |
S
Sale
|
Chairman & CEO
Executive Director
|
394,861
-7.6%
16.45
US$6,495,463
|
394,861
-7.6%
|
16.45
|
US$6,495,463
|
|
|
2025-12-10 |
2025-12-08 |
S
Sale
|
Chairman & CEO
Executive Director
|
315,896
-36.4%
16.45
US$5,196,489
|
315,896
-36.4%
|
16.45
|
US$5,196,489
|
|
|
2025-12-08 |
2025-12-08 |
PrS
Proposed sale
|
Chairman, CEO
|
750,000
16.75
US$12,562,500
|
750,000
|
16.75
|
US$12,562,500
|
|
|
2025-12-05 |
2025-12-03 |
S
Sale
|
Non-Executive Director
Large shareholder
|
9,720,000
-22.2%
16.33
US$158,727,600
|
9,720,000
-22.2%
|
16.33
|
US$158,727,600
|
|
|
2025-12-05 |
2025-12-03 |
S
Sale
|
Non-Executive Director
Large shareholder
|
9,720,000
-22.2%
16.33
US$158,727,600
|
9,720,000
-22.2%
|
16.33
|
US$158,727,600
|
|
|
2025-12-05 |
2025-12-03 |
S
Sale
|
Non-Executive Director
Large shareholder
|
6,480,000
-22.2%
16.33
US$105,818,400
|
6,480,000
-22.2%
|
16.33
|
US$105,818,400
|
|
|
2025-12-04 |
2025-12-03 |
PrS
Proposed sale
|
Owner
|
1,295,747
16.33
US$21,159,549
|
1,295,747
|
16.33
|
US$21,159,549
|
|
|
2025-12-03 |
2025-12-03 |
PrS
Proposed sale
|
Owner
|
41,219
16.33
US$673,106
|
41,219
|
16.33
|
US$673,106
|
|
|
2025-12-03 |
2025-12-03 |
PrS
Proposed sale
|
Owner
|
5,143,033
16.33
US$83,985,729
|
5,143,033
|
16.33
|
US$83,985,729
|
|
|
2025-12-03 |
2025-12-03 |
PrS
Proposed sale
|
Affiliate
|
9,720,000
16.84
US$163,684,800
|
9,720,000
|
16.84
|
US$163,684,800
|
|
|
2025-11-12 |
2025-11-10 |
S
Sale
|
Non-Executive Director
Large shareholder
|
12,000,000
-29.1%
15.65
US$187,812,000
|
12,000,000
-29.1%
|
15.65
|
US$187,812,000
|
|
|
2025-11-12 |
2025-11-10 |
S
Sale
|
Non-Executive Director
Large shareholder
|
18,000,000
-29.1%
15.65
US$281,718,000
|
18,000,000
-29.1%
|
15.65
|
US$281,718,000
|
|
|
2025-11-12 |
2025-11-10 |
S
Sale
|
Non-Executive Director
Large shareholder
|
18,000,000
-29.1%
15.65
US$281,718,000
|
18,000,000
-29.1%
|
15.65
|
US$281,718,000
|
|
|
2025-09-09 |
2025-09-05 |
S
Sale
|
Non-Executive Director
Large shareholder
|
12,000,000
-16.3%
15.11
US$181,332,000
|
12,000,000
-16.3%
|
15.11
|
US$181,332,000
|
|
|
2025-09-09 |
2025-09-05 |
S
Sale
|
Non-Executive Director
Large shareholder
|
12,000,000
-16.3%
15.11
US$181,332,000
|
12,000,000
-16.3%
|
15.11
|
US$181,332,000
|
|
|
2025-09-09 |
2025-09-05 |
S
Sale
|
Non-Executive Director
Large shareholder
|
8,000,000
-16.3%
15.11
US$120,888,000
|
8,000,000
-16.3%
|
15.11
|
US$120,888,000
|
|
|
2025-08-26 |
2025-08-22 |
S
Sale
|
President of Sterigenics
Officer
|
126,611
-22.0%
16.38
US$2,074,306
|
126,611
-22.0%
|
16.38
|
US$2,074,306
|
|
|
2025-08-22 |
2025-08-22 |
PrS
Proposed sale
|
Officer
Officer
|
126,611
16.12
US$2,040,969
|
126,611
|
16.12
|
US$2,040,969
|
|
|
2024-09-09 |
2024-09-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
10,000,000
-16.9%
15.03
US$150,300,000
|
10,000,000
-16.9%
|
15.03
|
US$150,300,000
|
|
|
2024-09-09 |
2024-09-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
15,000,000
-16.9%
15.03
US$225,450,000
|
15,000,000
-16.9%
|
15.03
|
US$225,450,000
|
|
|
2024-09-09 |
2024-09-06 |
S
Sale
|
Non-Executive Director
Large shareholder
|
15,000,000
-16.9%
15.03
US$225,450,000
|
15,000,000
-16.9%
|
15.03
|
US$225,450,000
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Non-Executive Director
|
5,750
-6.2%
14.31
US$82,268
|
5,750
-6.2%
|
14.31
|
US$82,268
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Non-Executive Director
Large shareholder
|
16,594,363
-15.7%
14.31
US$237,423,849
|
16,594,363
-15.7%
|
14.31
|
US$237,423,849
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Non-Executive Director
Large shareholder
|
16,594,363
-15.7%
14.31
US$237,423,849
|
16,594,363
-15.7%
|
14.31
|
US$237,423,849
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Non-Executive Director
Large shareholder
|
11,062,908
-15.7%
14.31
US$158,282,556
|
11,062,908
-15.7%
|
14.31
|
US$158,282,556
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Chairman & CEO
Officer
|
1,003,870
-15.5%
14.31
US$14,362,870
|
1,003,870
-15.5%
|
14.31
|
US$14,362,870
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
President of Sterigenics
Officer
|
83,109
-13.2%
14.31
US$1,189,082
|
83,109
-13.2%
|
14.31
|
US$1,189,082
|
|
|
2021-03-24 |
2021-03-22 |
S
Sale
|
Non-Executive Director
Large shareholder
|
13,512,582
-11.4%
26.12
US$352,982,423
|
13,512,582
-11.4%
|
26.12
|
US$352,982,423
|
|
|
2021-03-24 |
2021-03-22 |
S
Sale
|
Chairman & CEO
Executive Director
|
817,439
-11.4%
26.12
US$21,353,550
|
817,439
-11.4%
|
26.12
|
US$21,353,550
|
|
|
2021-03-24 |
2021-03-22 |
S
Sale
|
SVP, GC and Secretary
Officer
|
41,952
-11.4%
26.12
US$1,095,891
|
41,952
-11.4%
|
26.12
|
US$1,095,891
|
|
|
2021-03-24 |
2021-03-22 |
S
Sale
|
Non-Executive Director
Large shareholder
|
13,512,582
-11.4%
26.12
US$352,982,423
|
13,512,582
-11.4%
|
26.12
|
US$352,982,423
|
|
|
2021-03-24 |
2021-03-22 |
S
Sale
|
Non-Executive Director
Large shareholder
|
9,008,388
-11.4%
26.12
US$235,321,616
|
9,008,388
-11.4%
|
26.12
|
US$235,321,616
|
|